ATECNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Alphatec Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$10.41−0.05 (-0.48%)
Close on Oct 19, 2026
- Market cap
- $1.63B
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
69.6%−1.2 pts over 5 years
Operating margin
-10.7%+29.9 pts over 5 years
Net margin
-18.8%+35.8 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +25.0% | +29.6% | +39.5% | +19.0% | |
| Gross profit | +25.4% | +31.7% | +39.0% | +19.7% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 76.7% | -91.1% | 16449.6% | |
| Return on assets | -24.9% | -36.6% | -18.3% | |
| Current ratio | 1.81 | 3.16 | 2.06 | |
| Debt to equity | -1.11 | 0.36 | 50.74 | |
| Net debt to EBITDA | -8.83× | 1.28× | -101.31× | |
| Interest coverage | -2.9× | -4.8× | -1.8× | |
| Inventory turnover | 1.4× | 1.0× | 1.3× | |
| Capex to revenue | 7.4% | 16.0% | 5.6% | |
| Diluted shares | 9M | 67M | 150M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Alphatec generated $316.82M from operations and spent $349.18M on capital expenditure, dividends and share buybacks. 93% of that went back into the business.
Generated
$316.82M
Used
$349.18M
Capital expenditure$324.18M93%Dividends$00%Share buybacks$25.00M7%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-18.8%
×Asset turnover0.98×
×Equity multiplier-898.98×
=Return on equity, FY202516449.6%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -18.8% | 0.98× | -898.98× | 16449.6% |
| FY2024 | -26.5% | 0.77× | 24.72× | -507.1% |
| FY2023 | -38.7% | 0.73× | 30.52× | -859.1% |
| FY2022 | -43.1% | 0.64× | 23.76× | -657.7% |
| FY2021 | -58.8% | 0.58× | 3.96× | -135.9% |
| FY2020 | -54.5% | 0.67× | 2.48× | -91.1% |
| FY2019 | -50.3% | 0.76× | 4.89× | -186.3% |
| FY2018 | -31.6% | 0.86× | -23.57× | 637.9% |
| FY2017 | -2.3% | 1.14× | -2.62× | 6.7% |
| FY2016 | -24.9% | 1.00× | -3.08× | 76.7% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
6of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero-$143.36M
- Cash generatingOperating cash flow above zero$45.23M
- Return on assets improvedROA up on the prior year-20.1% → -18.5%
- Earnings backed by cashOperating cash flow above net income$45.23M vs -$143.36M
- Less leverageLong-term debt to assets fell74.1% → 63.4%
- Better liquidityCurrent ratio rose2.73 → 2.06
- No dilutionShare count did not rise143M → 150M
- Gross margin improvedGross margin up on the prior year69.37% → 69.60%
- More efficientAsset turnover rose0.76 → 0.99